openPR Logo
Press release

Genitourinary Drugs Market Analysis - Growing Concerns about Urinary Incontinence and Impotency | Astellas, Betanis, Botox, Glaxo Wellcome Plc, Anturol, Agouron Pharmaceuticals Inc., Chiron Inc

05-22-2020 09:49 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Genitourinary Drugs Market- Industry Trends and Forecast to 2026

Global Genitourinary Drugs Market- Industry Trends and Forecast to 2026

The Global Genitourinary Drugs Market report discusses about significant industry trends, estimations of market size and market share. The company profiles of all the top players and brands that are leading the Genitourinary Drugs Market with moves like product launches, joint ventures, mergers and acquisitions which in turn is affecting the sales, import, export, revenue and CAGR values are revealed in this market report. Different markets, marketing strategies, trends, future products and emerging opportunities are taken into account while studying market and preparing this report. The Genitourinary Drugs Market research report also puts light on the various inhibitors and motivators of the product market in both quantitative and qualitative approach so that users get accurate information.

The Global Genitourinary Drugs Market is expected to rise from its initial estimated value of USD 31.18 billion in 2018 to an estimated value of USD 40.74 billion by 2026 registering a CAGR of 3.4% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising number of pipeline drugs and prevalence of genitourinary disorders.

Get a Sample Report Now @

Genitourinary drugs are applicable in the treatment of various cancers, related to the bladder, kidney, urethra and ureters. Various steroids and immunosuppressants are available which leads the side effects in the treatment of related indications. Various biologics products have been developed to treat the infections of genitourinary with less side effects or no side effect such as darifenacin, fesoterodine, VESIcare, tolterodine and many more. Various genitourinary disorders such as urinary tract infections, polycystic kidney disease, glomerulonephritis, prostate cancer and others enhancing the utilization of genitourinary drugs for the treatment of patients.

Prominent Players are

Glaxo Wellcome Plc,
Eli Lilly,
Bayer AG,
Merck KGaA,
Abbott Laboratories,
Merck & Co.,
Agouron Pharmaceuticals Inc.,
Chiron Inc.,
Bristol-Myers Squibb Co.,
Connaught Laboratories Inc.,
Genentech Inc.,
Hoffman-La Roche Inc.,
Immunex Corp.,
Isis Pharmaceuticals,
Pharmacia & John Inc.,
Quadra Logic Technologies Inc.,
Rhone Poulenc Rorer Inc.,
Schering Plough Corp.,

In September 2018, TherapeuticsMD, Inc. announced the commercial availability of the Imvexxy 4 mcg in U.S. for the treatment of dyspareunia.

In May 2016, Genentech, Inc. announced the FDA approval of its product Atezolizumab which is a anti-PD-L1 cancer immunotherapy and used for the patients with the urothelial carcinoma.

Competitive Analysis: Global Genitourinary Drugs Market

The global genitourinary drugs market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of genitourinary drugs market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Enquire here:

Market Drivers:

Increasing incidences of urinary diseases and related illness that are sexually transmitted.
Growing concerns about urinary incontinence and impotency
Market Restraints:

Increasing advent of counterfeit drugs
Lack of compliance to medication

Market Segmentation: Genitourinary Drugs Market

By Disease
Prostate Cancer
Ovarian Cancer
Bladder Cancer
Cervical Cancer
Kidney/Renal Cancer
Genitourinary Cancer

By Products
Sex Hormones
Genitourinary Anti-Infective

By Geography

North America
South America
Rest of South America
United Kingdom

Don't miss out on business opportunities in Genitourinary Drugs Market. Speak to our analyst and gain crucial industry insights that will help your business grow.


Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475


Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Genitourinary Drugs Market Analysis - Growing Concerns about Urinary Incontinence and Impotency | Astellas, Betanis, Botox, Glaxo Wellcome Plc, Anturol, Agouron Pharmaceuticals Inc., Chiron Inc here

News-ID: 2055601 • Views: 291

More Releases from Data Bridge Market Research

Scars Treatment Market is Thriving Worldwide in Pharmaceutical Industry | CCA In …
This Scars Treatment Market analysis report evaluates the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. Integrated approaches and latest technology have been exploited for the best results while generating this report. Key elements covered in this business report are industry outlook along with critical success factors, industry dynamics, market definition, drivers and
Sarcoidosis Drug Market Shows Huge Growth by 2026 with Top Key Companies - Epizy …
Sarcoidosis Drug Market report also defines a chapter on the global market and allied companies with their profiles, which provides important data pertaining to their insights in terms of finances, product portfolios, investment plans, and marketing and business strategies. The report helps strengthen an organization and make better decisions for driving the business on right track. Global Sarcoidosis Drug Market report gives information about company profile, product specifications, capacity, production
Over the Counter (OTC) Drugs Market to Reach at a CAGR of 8.7% by 2026 with Top …
According to this wide ranging Global Over the Counter (OTC) Drugs Market report, the global market is anticipated to witness a relatively higher growth rate during the forecast period. The key research methodology here by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Under market segmentation, research and analysis is done based on
Haemophilus Influenzae Infection Treatment Market 2020 Comprehensive Study by To …
For drafting sustainable and profitable business strategies, Haemophilus Influenzae Infection Treatment Market report acts as a valuable and actionable resource of market insights that are always significant. For better decision making, sustainable growth, and maximum revenue generation today's businesses call for comprehensive market research report. The market study of Haemophilus Influenzae Infection Treatment Market report helps businesses to define their own strategies about the development in the existing product, modifications

All 5 Releases

More Releases for Genitourinary

Global and Chinese Genitourinary Drugs Industry, 2018 Market Research Report
Global Genitourinary Drugs Market provides a basic overview of the markets including definitions, classifications, applications and industry chain structure. The Genitourinary Drugs Market analysis is provided for the international Industry including development trends, competitive landscape analysis, and key regions development status. The Genitourinary Drugs report provides key statistics on the market status of the Genitourinary Drugs Market manufacturers and is a valuable source of guidance and direction for companies and
Genitourinary Drugs Market Pegged for Robust Expansion by 2024
Genitourinary drugs are used to treat disorders affecting the kidneys, bladder, ureters, and urethra. Since long, patients suffering from disorders and infections related to genitourinary systems have been depending on steroids and immunosuppressants which are chemically synthesized and may reciprocate with some serious side effects such as insomnia, acne, nausea, vomiting, and diarrhea. As a result, patients are now turning to biological drugs that not only cause fewer to no
Genitourinary Drugs Market Pegged for Robust Expansion During 2016 - 2024
Genitourinary is a condition that deals with genital and urinary system. Genitourinary drugs are used to treat disorders related to kidney, ureters, bladder and urethra. The diagnosis of the genitourinary system involves the entire urinary tract and male genital tract. Genitourinary infections may be communicable and caused by organisms such as bacteria or yeast. It is estimated that one in five women will suffer from urinary tract infection in
Genitourinary Drugs Market Record an Exponential CAGR by 2024
Genitourinary cancers are cancer in the urinary system e.g. prostate cancer, ovarian cancer, bladder cancer and cervical cancer. Growing incidence of genitourinary disorder will drive genitourinary drug market. Many pipeline drugs are under development that will expand the scope in the next few years. A sample of this report is available upon request @ Increased demand of generics, continual patent expiration and the presence of counterfeit drugs is expected
United States Genitourinary Drugs Market: By Applications - Genitourinary Cancer …
Latest industry research report on: United States Genitourinary Drugs Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Download Sample copy of this Report at : This report studies sales (consumption) of Genitourinary Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Astellas Pfizer GlaxoSmithKline
Global Genitourinary Drugs Market Trends, Competitive Analysis, Research Report …
Genitourinary Drugs Market size is driven by increasing prevalence of genitourinary disorders, rising disposable incomes, and constant improvements in healthcare infrastructure over the forecast timeframe. Genitourinary Drugs Market size will witness a considerable growth over the forecast period. Patients with diabetes are highly susceptible to suffer from urinary tract infections. Women are more disposed to this problem due to the short length of urethra that facilitates easier entry of microorganisms. Global